Exact Mass: 301.0442

Exact Mass Matches: 301.0442

Found 81 metabolites which its exact mass value is equals to given mass value 301.0442, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Acetylglucosamine 6-sulfate

N-Acetyl-D-glucosamine 6-sulfate

C8H15NO9S (301.0468)


   

N-Acetylglucosamine 4-sulfate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

Nocodazole

(5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl)-carbamic acid methyl ester

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

N-Acetylgalactosamine 4-sulphate

N-[(2R,3R,4R,5R,6R)-2,4-Dihydroxy-6-(hydroxymethyl)-5-(sulphooxy)oxan-3-yl]ethanimidic acid

C8H15NO9S (301.0468)


Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate. [HMDB] Also known as GalNAc4S, this molecule is a key component of dermatan, keratan and chondroitin sulfate. It is also a substrate for the enzyme N-acteylgalactosamine-4-sulphate transferase. This molecule is found in elevated concentrations in the urine of patients suffering from muchopolysaccharidosis type III, IV and VI. Levels are typically 300-400 times normal values. GalNAc4S is thought to be derived from the action of beta-N-acetylhexosaminidase on sulphated GlcNAc or GalNAc residues at the non-reducing end of keratan sulphate, dermatan sulphate or chondroitin sulphate.

   

Benoxaprofen

()-2-(4-chlorophenyl)benzoxazole-5-propionic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

N-Acetylgalactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


KEIO_ID A184

   

N-Acetylglucosamine 6-sulfate

{[(2R,3S,4R,5R,6R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methoxy}sulfonic acid

C8H15NO9S (301.0468)


N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730) [HMDB] N-acetylglucosamine 6-sulfate is a physiological intermediate during the degradation of keratan sulfate and it is usually hydrolyzed intralysosomally by N-acetylglucosamine-6-sulfate sulfatase. (PMID 3161730).

   

N-Acetylgalactosamine 6-sulfate

N-[(2R,3R,4R,5R)-3,4,5-Trihydroxy-1-oxo-6-(sulphooxy)hexan-2-yl]ethanimidic acid

C8H15NO9S (301.0468)


N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate. PMID: 12489154. Morquio syndrome is caused by an abnormal accumulation of mucopolysaccharides - in this case, keratan sulfate - in the body. Keratan sulfate is excreted in urine. The symptoms vary from patient to patient, and may include hearing loss, cataracts, skeletal dysplasia, spinal instability, and minor respiratory issues, among others. Two forms are recognized, type A and type B. Type A is a deficiency of the enzyme N-acetylgalactosamine-6-sulfate sulfatase. (Wikipedia). N-Acetylgalactosamine 6-sulfate is found in keratan sulfate and chondroitin 6-sulfate.

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

Benoxaprofen

2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid

C16H12ClNO3 (301.0506)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

   

N-Acetyl-D-galactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

(2-TRIFLUOROMETHYL-QUINOLIN-4-YLSULFANYL)-ACETIC ACID HYDRAZIDE

C12H10F3N3OS (301.0497)


   
   

5-benzyl-4-(4-chlorophenyl)-4H-1,2,4-triazole-3-thiol

5-benzyl-4-(4-chlorophenyl)-4H-1,2,4-triazole-3-thiol

C15H12ClN3S (301.044)


   

Maybridge3_001335

Maybridge3_001335

C15H12ClN3S (301.044)


   

N-Acetylgalactosamine 4-sulphate

N-Acetylgalactosamine 4-sulphate

C8H15NO9S (301.0468)


   

4-CHLORO-2-PYRIDIN-3-YL-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDINE

4-CHLORO-2-PYRIDIN-3-YL-5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDINE

C15H12ClN3S (301.044)


   

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

7-chloro-4-hydroxy-3-(4-methoxyphenyl)-1H-quinolin-2-one

C16H12ClNO3 (301.0506)


   

1-Benzhydryl-3-bromoazetidine

1-Benzhydryl-3-bromoazetidine

C16H16BrN (301.0466)


   

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrochloride

C11H13Cl2N5O (301.0497)


   

2-THIAZOLECARBOXYLICACID,4-[3-(TRIFLUOROMETHYL)PHENYL]-,ETHYLESTER

2-THIAZOLECARBOXYLICACID,4-[3-(TRIFLUOROMETHYL)PHENYL]-,ETHYLESTER

C13H10F3NO2S (301.0384)


   

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

1-[3-(4-Bromo-2-fluorophenoxy)propyl]pyrrolidine

C13H17BrFNO (301.0477)


   

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

ethyl 2-[(2-chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C13H16ClNO3S (301.0539)


   

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

(Z)-2-BENZAMIDO-3-(2-CHLOROPHENYL)ACRYLIC ACID

C16H12ClNO3 (301.0506)


   

1-(benzenesulfonyl)indole-2-carboxylic acid

1-(benzenesulfonyl)indole-2-carboxylic acid

C15H11NO4S (301.0409)


   

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

N-(4-(N-(Thiazol-2-yl)sulfamoyl)phenyl)acetamide-d4

C11H7D4N3O3S2 (301.0493)


   

2-methyl-3-(3-sulfatobutyl)benzothiazolium betaine

2-methyl-3-(3-sulfatobutyl)benzothiazolium betaine

C12H15NO4S2 (301.0442)


   

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

ETHYL 2-CHLORO-2-(2-(4-METHOXY-2-NITROPHENYL)HYDRAZONO)ACETATE

C11H12ClN3O5 (301.0465)


   

1-(PHENYLSULFONYL)-1H-INDOLE-3-CARBOXYLIC ACID

1-(PHENYLSULFONYL)-1H-INDOLE-3-CARBOXYLIC ACID

C15H11NO4S (301.0409)


   

ETHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4-CARBOXYLATE

ETHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-4-CARBOXYLATE

C13H10F3NO2S (301.0384)


   

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

2-(Butyryloxy)-N,N,N-trimethylethanaminium iodide

C9H20INO2 (301.0539)


   

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

1-(2-CHLORO-3-PYRIDYL)-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE

C14H11ClF3NO (301.0481)


   

4-BENZYL-5-(2-CHLORO-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-BENZYL-5-(2-CHLORO-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C15H12ClN3S (301.044)


   

Amiloride HCl dihydrate

Amiloride hydrochloride dihydrate

C6H13Cl2N7O3 (301.0457)


D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062686 - Epithelial Sodium Channel Blockers D049990 - Membrane Transport Modulators > D026941 - Sodium Channel Blockers > D062646 - Acid Sensing Ion Channel Blockers C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

2-BROMO-5-FLUORO-N,N-DIISOPROPYLBENZAMIDE

C13H17BrFNO (301.0477)


   

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

4-benzyl-5-(4-chloro-phenyl)-4h-[1,2,4]triazole-3-thiol

4-benzyl-5-(4-chloro-phenyl)-4h-[1,2,4]triazole-3-thiol

C15H12ClN3S (301.044)


   

5-methoxy-2-methyl-3-(3-sulfopropyl)benzothiazolium inner salt

5-methoxy-2-methyl-3-(3-sulfopropyl)benzothiazolium inner salt

C12H15NO4S2 (301.0442)


   

2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

C13H10F3NO2S (301.0384)


   

3,5-Bis(trifluoromethyl)-DL-phenylalanine

3,5-Bis(trifluoromethyl)-DL-phenylalanine

C11H9F6NO2 (301.0537)


   

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-BENZYL-7-(METHYLTHIO)-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C14H11N3O3S (301.0521)


   

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

(6-bromopyridin-2-yl)methoxy-tert-butyl-dimethylsilane

C12H20BrNOSi (301.0497)


   

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-5-(2-FURYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C14H11N3O3S (301.0521)


   

methyl 2-[2-(trifluoromethyl)quinolin-4-yl thio]-acetate

methyl 2-[2-(trifluoromethyl)quinolin-4-yl thio]-acetate

C13H10F3NO2S (301.0384)


   

ethyl 2-(2-amino-5,6-dichloro-4H-quinazolin-3-yl)acetate

ethyl 2-(2-amino-5,6-dichloro-4H-quinazolin-3-yl)acetate

C12H13Cl2N3O2 (301.0385)


   

tert-Butyl1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

tert-Butyl1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

3-(4-chlorophenyl)-4-(4-methylphenyl)-1H-1,2,4-triazole-5-thione

3-(4-chlorophenyl)-4-(4-methylphenyl)-1H-1,2,4-triazole-5-thione

C15H12ClN3S (301.044)


   

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

tert-Butyl 3-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate

C11H16BrN3O2 (301.0426)


   

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

3-AMINO-3-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID

C11H9F6NO2 (301.0537)


   

Ro 41-1049 hydrochloride

Ro 41-1049 hydrochloride

C12H13ClFN3OS (301.0452)


   

4-nitro-N-(phenylthiocarbamoyl)benzamide

4-nitro-N-(phenylthiocarbamoyl)benzamide

C14H11N3O3S (301.0521)


   

1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-beta-methoxy-alpha-methyl-

1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-dichlorophenyl)-beta-methoxy-alpha-methyl-

C12H13Cl2N3O2 (301.0385)


   

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

N-[(3-nitroanilino)-sulfanylidenemethyl]benzamide

C14H11N3O3S (301.0521)


   

3-(4-Chlorophenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

3-(4-Chlorophenyl)-6-phenyl-1,4-dihydro-1,3,5-triazine-2-thione

C15H12ClN3S (301.044)


   

nocodazole

nocodazole

C14H11N3O3S (301.0521)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents Same as: D05197

   

2-(Acetylamino)-2-Deoxy-6-O-Sulfo-alpha-D-Glucopyranose

N-{2,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-3-yl}ethanimidic acid

C8H15NO9S (301.0468)


   

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

2-(Acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose

C8H15NO9S (301.0468)


   

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

Methyl 2,2-dichloro-3-hydroxy-4-(methoxycarbonylamino)-5-methylhexanoate

C10H17Cl2NO5 (301.0484)


   

Quercetin-7-olate

Quercetin-7-olate

C15H9O7- (301.0348)


Conjugate base of quercetin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   
   

Tricetin(1-)

Tricetin(1-)

C15H9O7- (301.0348)


The conjugate base of tricetin arising from selective deprotonation of the 7-OH position; major species at pH 7.3.

   

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

6-O-Sulfo-2-(acetylamino)-2-deoxy-D-glucopyranose

C8H15NO9S (301.0468)


   

5,7,8,3,4-Pentahydroxyflavone

5,7,8,3,4-Pentahydroxyflavone

C15H9O7- (301.0348)


   

n-Acetylgalactosamine-6-sulfate

n-Acetylgalactosamine-6-sulfate

C8H15NO9S (301.0468)


   

4-[(Z)-(4,6-dihydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]-2,6-dihydroxyphenolate

4-[(Z)-(4,6-dihydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]-2,6-dihydroxyphenolate

C15H9O7- (301.0348)


   

N-Acetyl-alpha-D-glucosamine 3-sulfate

N-Acetyl-alpha-D-glucosamine 3-sulfate

C8H15NO9S (301.0468)


   

3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-olate

3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-olate

C15H9O7- (301.0348)


   

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

N-(3-(2-Nitrophenyl)-2-propenylidene)-2-thiophenecarbohydrazide

C14H11N3O3S (301.0521)


   

N-benzyl-2,3,4,5,6-pentafluorobenzamide

N-benzyl-2,3,4,5,6-pentafluorobenzamide

C14H8F5NO (301.0526)


   

N-Acetylgalactosamine 4-sulfate

N-Acetyl-D-galactosamine 4-sulfate

C8H15NO9S (301.0468)


   

1-Carboxy-1-[(dimethylamino)-carbonyl]ferrocene

1-Carboxy-1-[(dimethylamino)-carbonyl]ferrocene

C14H15FeNO3-6 (301.0401)


   
   

2-Thiophenecarboxylic acid 2-(1,3-dioxo-2-isoindolyl)ethyl ester

2-Thiophenecarboxylic acid 2-(1,3-dioxo-2-isoindolyl)ethyl ester

C15H11NO4S (301.0409)


   

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

N-(2,1,3-benzothiadiazol-5-yl)-2,4-dimethyl-6-oxo-3-pyrancarboxamide

C14H11N3O3S (301.0521)


   

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

(E)-3-[3-[(4-chlorobenzoyl)amino]phenyl]prop-2-enoic acid

C16H12ClNO3 (301.0506)


   

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

Benzaldehyde, o-[(pentafluorophenyl)methyl]oxime

C14H8F5NO (301.0526)


   

N-Acetyl-D-galactosamine 6-sulfate

N-Acetyl-D-galactosamine 6-sulfate

C8H15NO9S (301.0468)


   

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

2-Deoxy-2-acetamido-beta-D-galactose-4-sulfate

C8H15NO9S (301.0468)


   

delphinidin(1-)

delphinidin(1-)

C15H9O7 (301.0348)


An organic anion obtained by selective deprotonation of the 3- and 5-hydroxy groups of delphinidin; major species at pH 7.3.

   

Muscarine (iodide)

Muscarine (iodide)

C9H20INO2 (301.0539)


Muscarine ((+)-Muscarine) iodide is a toxin that can stimulate the parasympathetic nervous system. Muscarine iodide is a prototype muscarinic acetylcholine receptor agonist[1][2].

   

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

(3s,3ar)-7-chloro-5-(cyanomethyl)-3a-hydroxy-3h-cyclopenta[a]inden-3-yl acetate

C16H12ClNO3 (301.0506)